Literature DB >> 9498759

Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR.

M Szamel1, A Appel, R Schwinzer, K Resch.   

Abstract

Stimulation of purified human PBL with mAbs raised against the T cell receptor resulted in an immediate and transient activation of protein kinase C-alpha (PKC-alpha) and PKC-theta, peaking at 10 min, whereas PKC-beta, -delta, and -epsilon were translocated with a delay of >90 min and remained activated for up to 2 h. To characterize specific functions of distinct PKC isoenzymes, Abs against different PKC isoenzymes were introduced by means of electropermeabilization. Neutralization of PKC-alpha and -theta resulted in the complete inhibition of IL-2R expression, whereas anti-PKC-beta, -delta, and -epsilon Abs inhibited IL-2 synthesis. Extensive control experiments have shown that neither electropermeabilization nor control Ig influenced PKC activity and cellular functions. Our data thus clearly show that specific PKC isoenzymes regulate different cellular functions in stimulated human lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498759

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

3.  Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta.

Authors:  X Lin; A O'Mahony; Y Mu; R Geleziunas; W C Greene
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  NFAT and NFkappaB activation in T lymphocytes: a model of differential activation of gene expression.

Authors:  Wayne G Fisher; Pei-Chi Yang; Ram K Medikonduri; M Saleet Jafri
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

5.  Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.

Authors:  Yu Liu; Ren Song; Yan Gao; Yi Li; Shuai Wang; Hai-Yun Liu; Yan Wang; Yun-Hong Hu; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

6.  Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.

Authors:  Sergey A Trushin; Kevin N Pennington; Eva M Carmona; Susana Asin; Doris N Savoy; Daniel D Billadeau; Carlos V Paya
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse.

Authors:  Jianyong Huang; Pei-Fen Lo; Tomasz Zal; Nicholas R J Gascoigne; Brian A Smith; Steven D Levin; Howard M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-20       Impact factor: 11.205

8.  Involvement of protein kinase C-delta in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YT.

Authors:  F J Kos; H D Bear
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

9.  Nifetepimine, a dihydropyrimidone, ensures CD4+ T cell survival in a tumor microenvironment by maneuvering sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA).

Authors:  Swatilekha Ghosh; Arghya Adhikary; Samik Chakraborty; Pinki Nandi; Suchismita Mohanty; Supriya Chakraborty; Pushpak Bhattacharjee; Sanhita Mukherjee; Salil Putatunda; Srabasti Chakraborty; Arijit Chakraborty; Gaurisankar Sa; Tanya Das; Parimal C Sen
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

10.  Involvement of distinct PKC gene products in T cell functions.

Authors:  Christa Pfeifhofer-Obermair; Nikolaus Thuille; Gottfried Baier
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.